AUPN583995A0 - Pilosulin - Google Patents

Pilosulin

Info

Publication number
AUPN583995A0
AUPN583995A0 AUPN5839A AUPN583995A AUPN583995A0 AU PN583995 A0 AUPN583995 A0 AU PN583995A0 AU PN5839 A AUPN5839 A AU PN5839A AU PN583995 A AUPN583995 A AU PN583995A AU PN583995 A0 AUPN583995 A0 AU PN583995A0
Authority
AU
Australia
Prior art keywords
pilosulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPN5839A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northern Sydney Area Health Service
Original Assignee
Baldo B A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baldo B A filed Critical Baldo B A
Priority to AUPN5839A priority Critical patent/AUPN583995A0/en
Publication of AUPN583995A0 publication Critical patent/AUPN583995A0/en
Assigned to NORTHERN SYDNEY AREA HEALTH SERVICE reassignment NORTHERN SYDNEY AREA HEALTH SERVICE Assignment by Applicant under S 113 Assignors: Baldo, Brian A, DONOVAN, GREGORY
Priority to PCT/AU1996/000632 priority patent/WO1997013854A1/en
Priority to AU71212/96A priority patent/AU728795B2/en
Priority to JP9514570A priority patent/JPH11514230A/en
Priority to EP96932384A priority patent/EP0862626A4/en
Priority to CA002232231A priority patent/CA2232231A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Insects & Arthropods (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AUPN5839A 1995-10-09 1995-10-09 Pilosulin Abandoned AUPN583995A0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AUPN5839A AUPN583995A0 (en) 1995-10-09 1995-10-09 Pilosulin
PCT/AU1996/000632 WO1997013854A1 (en) 1995-10-09 1996-10-09 Pilosulin 2
AU71212/96A AU728795B2 (en) 1995-10-09 1996-10-09 Pilosulin 2
JP9514570A JPH11514230A (en) 1995-10-09 1996-10-09 Pyrosulin 2
EP96932384A EP0862626A4 (en) 1995-10-09 1996-10-09 Pilosulin 2
CA002232231A CA2232231A1 (en) 1995-10-09 1996-10-09 Pilosulin 2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPN5839A AUPN583995A0 (en) 1995-10-09 1995-10-09 Pilosulin

Publications (1)

Publication Number Publication Date
AUPN583995A0 true AUPN583995A0 (en) 1995-11-02

Family

ID=3790167

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPN5839A Abandoned AUPN583995A0 (en) 1995-10-09 1995-10-09 Pilosulin

Country Status (5)

Country Link
EP (1) EP0862626A4 (en)
JP (1) JPH11514230A (en)
AU (1) AUPN583995A0 (en)
CA (1) CA2232231A1 (en)
WO (1) WO1997013854A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3594226A1 (en) * 2018-07-13 2020-01-15 Institut National Universitaire Champollion Ant venom peptidome

Also Published As

Publication number Publication date
WO1997013854A1 (en) 1997-04-17
EP0862626A1 (en) 1998-09-09
CA2232231A1 (en) 1997-04-17
EP0862626A4 (en) 1999-07-07
JPH11514230A (en) 1999-12-07

Similar Documents

Publication Publication Date Title
AU5235796A (en) o-hydroxyphenyl-s-triazines
AU4780896A (en) Core-board
AU6000496A (en) Phenylpyridazinones
AU5896396A (en) Pyridine-microbicides
AU1030997A (en) Taphane
AU4996696A (en) 2-benzyl-3-arylbenzothiophenes
AU5147496A (en) Fucopeptides
AU6235496A (en) Azothiophenes
AU5593896A (en) Benzisothiazolyl-substituted aminomethylchromans
AU5500196A (en) Anti-transpirants
AU4382896A (en) Acetylimidazobenzodiazepines
AU7038196A (en) 1-azinyl-tetrazolinones
AU5108596A (en) Morphine-3-esters
AU6215196A (en) Piperidinylmethyloxazolidinones
AU5917896A (en) Poly-beta-1-4-N-acetylglucosamine
AU5013796A (en) Wireclamp
AU5107096A (en) Haemodialyser
AU4569496A (en) Tetralinyl- and indanyl-ethylamides
AU7694696A (en) Cyclopeptolides
AU6840796A (en) Sack-holder
AU6658396A (en) Polyhydroxyalkylamidobetaine
AU7565396A (en) Fluorobutenoyloxyacetamides
AU5878096A (en) Fasciotome
AU7594496A (en) Twinpiano
AU4831396A (en) Pyrazolotetracyclines